Exploring the views of infection consultants in England on a novel delinked funding model for antimicrobials: the SMASH study

OBJECTIVES: A novel ‘subscription-type’ funding model was launched in England in July 2022 for ceftazidime/avibactam and cefiderocol. We explored the views of infection consultants on important aspects of the delinked antimicrobial funding model. METHODS: An online survey was sent to all infection c...

Descripción completa

Detalles Bibliográficos
Autores principales: Baltas, Ioannis, Gilchrist, Mark, Koutoumanou, Eirini, Gibani, Malick M, Meiring, James E, Otu, Akaninyene, Hettle, David, Thompson, Ameeka, Price, James R, Crepet, Anna, Atomode, Abolaji, Crocker-Buque, Timothy, Spinos, Dimitrios, Guyver, Hudson, Tausan, Matija, Somasunderam, Donald, Thoburn, Maxwell, Chan, Cathleen, Umpleby, Helen, Sharp, Bethany, Chivers, Callum, Vaghela, Devan Suresh, Shah, Ronak J, Foster, Jonathan, Hume, Amy, Smith, Christopher, Asif, Ammara, Mermerelis, Dimitrios, Reza, Mohammad Abbas, Haigh, Dominic A, Lamb, Thomas, Karatzia, Loucia, Bramley, Alexandra, Kadam, Nikhil, Kavallieros, Konstantinos, Garcia-Arias, Veronica, Democratis, Jane, Waddington, Claire S, Moore, Luke S P, Aiken, Alexander M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391702/
https://www.ncbi.nlm.nih.gov/pubmed/37533762
http://dx.doi.org/10.1093/jacamr/dlad091

Ejemplares similares

Ejemplares similares